Analystreport

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.

AcelRx Pharmaceuticals, Inc.  (ACRX) 
Last acelrx pharmaceuticals, inc. earnings: 3/16 07:35 am Check Earnings Report
US:NASDAQ Investor Relations: ir.acelrx.com/investor-relations